Data from the long-running HOME study links higher exposure to certain polyfluoroalkyl substances ‘forever chemicals’ with ...

Insights from AHS 2026, including anticipated presentations, key takeaways, and how new research in migraine treatment will affect patient care.

She’d diagnosed rheumatoid arthritis dozens of times but dismissed her own symptoms and fought her eventual diagnosis. Today ...

A higher intake of several food colouring additives is associated with an increased risk of developing type 2 diabetes, an ...

Endovascular thrombectomy with medical management improves functional independence vs medical management alone in stroke due ...

A French study shows that kidney biopsy during early pregnancy appears safe — with only one patient with serious bleeding ...

Members of the writing committee for the 2026 ACC/AHA/Multisociety dyslipidemia guidelines respond to a critical column by John Mandrola, MD.

Survey respondents open up about how work affects their relationships and how being a physician affects the search for an appropriate partner.

The FDA has approved durvalumab (Imfinzi, AstraZeneca) in combination with Bacillus Calmette-Guerin (BCG) for adults with BCG-naive, high-risk non-muscle-invasive bladder cancer (NIMBC). Approval was ...

Familial hidradenitis suppurativa is associated with higher risks for metabolic and cardiovascular diseases than sporadic hidradenitis suppurativa, a study suggests.

Blood eosinophil counts may help predict the risk for exacerbations in patients with asthma, but fractional exhaled nitric oxide shows mixed results and may be less useful in COPD.

New study results suggest high-sensitivity C-reactive protein may provide a more accurate picture of disease activity in patients with psoriatic arthritis.